MatrixCell Bio is a Korean biostartup company providing solutions to regenerative and reconstructive manufacturing of tissue engineering products through mobile and stationary 3D bioprinting systems (bioinks, medical devices, and bioprinters).
Business Area
In the area of both 3D bioprinting technology and biopharma, our vision is to become the leading company in the field of regenerative medicine by contributing bioinks/hydrogels and tissue engineering equipment to the medical industry and academia. We have unique core technologies (biomaterials and equipment) for direct bioprinting in vivo and in vitro tissue engineering regenerative medicine.
